<DOC>
	<DOCNO>NCT01153165</DOCNO>
	<brief_summary>Purpose design : The relationship psychological morbidity asthma previously recognise , however little evidence regard link poor mental health asthma control people severe asthma . If evidence available show identify treat depression , result meaningful improvement people 's asthma symptom , would helpful change doctor ' approach people severe asthma , ensure physical mental wellbeing consider . This study double blind randomise placebo control pilot study aim identify ; treat depression patient well characterised refractory asthma improve depression asthma control . Forty patient meet inclusion criterion randomise either placebo anti-depressant medication group , neither participant researcher aware medication give . Patients recruit severe asthma ; identify depression use two validated questionnaire agree take part take anti-depressant medication . Patients poor adherence medication , respiratory condition anti-depressant medication previous 6 month exclude . Outcome measure depression questionnaire , quality life questionnaire , lung function , measure airways inflammation reduction dose oral steroid use determine effect anti-depressant medication depression asthma control . The treatment period 12 week outcomes assess first final week treatment . The investigator hope find study protocol devise feasible large multi-Centre clinical trial demonstrate evidence treat depression subject well characterise refractory asthma improve depression asthma symptom control ( use estimate size large clinical trial ) . Recruitment : Participants identify approached member usual healthcare team invite participate . Participants give time consider whether wish take part assure care unaffected choose participate withdraw study period . Inclusion/exclusion : All patient assess use well establish systematic evaluation protocol . Refractory asthma base definition American Thoracic Society Consensus Workshop . Patients recruit refractory asthma , identify depression use two validated questionnaire agree take part take anti-depressant medication . Patients poor adherence medication , respiratory condition anti-depressant medication previous 6 month exclude . Consent : People unable give inform consent exclude study may particularly vulnerable . Capacity give inform consent assess participant 's usual healthcare professional . Risks , burden benefit There small risk agitation suicidal ideation associate commencement selective serotonin reuptake inhibition ( SSRI ) anti-depressants . The investigator attempt minimise risk : 1 . Contacting participant 1 week commence treatment 1 week subsequent dose increase ensure suggestion agitation suicidal ideation . This accordance guideline initiation SSRI therapy adult . 2 . Participants also contact weekly 2 week discontinuation study treatment . If depressive symptom worsen patient advised liaise GP consider institution treatment clinical ground .</brief_summary>
	<brief_title>Study Treatment Depression Refractory Asthma</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>All patient assess use well establish systematic evaluation protocol . Refractory asthma base definition American Thoracic Society Consensus Workshop , purpose study define follow : Persisting symptom due asthma ( ACS ≥3 ) despite detail assessment management ( nonadherence , alternative diagnosis comorbidities etc ) ; Minimal maintenance therapy high dose inhale steroid ( ≥800 mg BDP equivalent ) long act Beta2agonist / maintenance therapy ( theophylline / leukotriene receptor antagonist ) . The requirement maintenance oral steroid ≥ 50 % year least 3 course systemic steroid precede 12 month . Inclusion criterion : Age 1865 year Refractory asthma Agreement take part trial take antidepressant medication Hospital Anxiety Depression Score ≥11 Hamilton Depression Rating Scale ≥ 17 Poor adherence medication ( prescription record , ≤50 % inhaled combination fill previous 6 month ) Significant comorbidity due condition asthma Antidepressant medication previous 3 month Pregnancy Patients require nonsteroidal antiinflammatory drug , aspirin warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Refractory</keyword>
	<keyword>Asthma</keyword>
	<keyword>Depression</keyword>
</DOC>